Fundamental analysis of $AZTA (Azenta, Inc.) based on financial data and reported results.

#AZTA

Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities BURLINGTON, Mass., March 4, 2026/ PRNewswire/-- Azenta, Inc., a leading provider of life science solutions, today announced that its wholly owned subsidiary, Azenta UK Ltd, has acquired UK Biocentre Limited, a leading provider of sample management, sample storage and high-throughput sample processing services in the United Kingdom. The acquisition strengthens...

#AZTA Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities

www.stocktitan.net/news/AZTA/azenta-complet...

Azenta Authorizes $250 Million Share Repurchase Program Azenta (Nasdaq: AZTA) announced a Board-approved $250 million share repurchase program.The program began on Dec 9, 2025 and runs through Dec 31, 2028 unless earlier extended or terminated. Repurchases may be executed via open-market purchases, privately negotiated transactions, or other methods compliant with Rules 10b-18 and 10b5-1. The authorization is discretionary and does not obligate Azenta to buy any specific dollar amount or number of shares; repurchases can be commenced, suspended, modified, or discontinued at any time.Management said the buyback is part of a capital allocation strategy alongside productivity, organic growth, and disciplined M&A to enhance long-term shareholder value.

#AZTA Azenta Authorizes $250 Million Share Repurchase Program

www.stocktitan.net/news/AZTA/azenta-authori...

Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025 BURLINGTON, Mass., Nov. 21, 2025/ PRNewswire/-- Azenta, Inc. today reported financial results for the fourth quarter and fiscal year ended September 30, 2025.. Revenue was $159 million, up 6% year over year. Organic revenue, which excludes the impact from foreign exchange, grew 4% year over year, mainly attributable to higher revenue in Multiomics. Sample Management...

#AZTA Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025

www.stocktitan.net/news/AZTA/azenta-reports...

Trade Alerts, Thursday September 11, 2025 – Crystal Equity Research

Small-cap stocks registering bullish MACD crossover signals, Thu Sept 11th - #VERO #SANA #RELL #AZTA #BWEN #CMMB #DERM #FLL #IMUX #LVO #MBIO #UDMY #TRUG #PDY #NVTS #YRD #UTL #LBRT - More: crystalequityresearch.com/trade-alerts... - #smallcap

Azenta Earnings Show Strong Margin Growth: CEO Details Operational Turnaround Success Despite Market Headwinds Azenta reports Q3 results with 12.3% EBITDA margin, improved cost management, and reaffirmed FY25 guidance. See detailed financial metrics and growth strategy.

#AZTA Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance

www.stocktitan.net/news/AZTA/azenta-reports...

35,000-Patient Genomics Study Launches to Revolutionize Kidney Disease Treatment: Major Partnership Announced New alliance combines 35,000-patient database with AI-powered genomics to unlock kidney disease breakthroughs. Discover how this partnership aims to transform patient care.

#AZTA Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology

www.stocktitan.net/news/AZTA/azenta-life-sc...

Fresenius Unveils Groundbreaking 35,000-Patient Genomics Program to Transform Kidney Disease Treatment New partnership combines 35,000-patient genomic database with AI technology to revolutionize personalized kidney care. Discover how this breakthrough shapes future treatments.

#FMS #AZTA Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care

www.stocktitan.net/news/FMS/fresenius-medic...

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with improving money flow, Wed Jul 9th - #XLO #TAOX #SBC #RAIL #PAHC #OABI #KALA #INBX #GSIT #CNXN #AZTA #LDI #GGT #DK #CPUH #BGR #ALUR - More: crystalequityresearch.com/SmCpStr/ - #smallcap

Revolutionary AI Partnership Promises to Cut Gene Therapy Development Time and Costs: Azenta Teams Up with Form Bio New AI-powered platform combines GENEWIZ sequencing with Form Bio's analysis to accelerate AAV gene therapy development. See how this breakthrough speeds up patient treatment.

#AZTA Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development

www.stocktitan.net/news/AZTA/azenta-life-sc...

Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 Azenta (NASDAQ: AZTA) reported its Q2 FY2025 financial results with revenue of $143 million, showing a 5% year-over-year increase and 6% organic growth. The company's Sample Management Solutions revenue grew 8% to $80 million, while Multiomics revenue increased 2% to $64 million. Despite revenue growth, Azenta reported a GAAP operating loss of $16 million with operating margin at -11.3%. The company maintained strong liquidity with $540 million in cash and equivalents. Adjusted EBITDA was $14 million with a 10% margin, showing a 400 basis point improvement year-over-year. Management reiterated its FY2025 guidance, expecting organic revenue growth of 3-5% and adjusted EBITDA margin expansion of approximately 300 basis points.

#AZTA Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025

www.stocktitan.net/news/AZTA/azenta-reports...

Azenta Posts Mixed Q1: Revenue Climbs, Margins Surge 400bps, But EPS Disappoints Azenta reports Q1 revenue of $148M (+4% YoY) with strong margin improvements, while facing challenges with operating loss. Maintains FY25 growth outlook amid solid cash position.

#AZTA Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024

www.stocktitan.net/news/AZTA/azenta-reports...

Azenta Wins Major UK Biocentre Contract for 16M-Sample Storage System Expansion Azenta's BioArc Ultra automated storage system will boost UK Biocentre's capacity by 16 million samples, supporting the landmark Our Future Health study of 5 million people.

#AZTA UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence

www.stocktitan.net/news/AZTA/uk-biocentre-s...

Buddhist Leader and Zen Teacher Peter Schneider Has Died at 87 - Buddhistdoor Global The longtime Soto Zen teacher inspired countless practitioners through his steadfast leadership and compassionate guidance

BDG news: ​​​​Buddhist Leader and Zen Teacher Peter Schneider Has Died at 87

Read here: tinyurl.com/47dctbs8

#buddhism #mahayana #soto #zen #usa #california #obituary #zazen #buddhistteacher #sfzc #azta #tzmc

#AZTA Azenta to Participate in Stephens Annual Investment Conference

www.stocktitan.net/news/AZTA/azenta-to-part...